NIRSEVIMAB-ALIP for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 16 adverse event reports in the FDA FAERS database where NIRSEVIMAB-ALIP was used for Product used for unknown indication.
Most Reported Side Effects for NIRSEVIMAB-ALIP
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 173 | 22.1% | 1 | 127 |
| Respiratory syncytial virus bronchiolitis | 135 | 17.2% | 1 | 72 |
| Bronchiolitis | 83 | 10.6% | 0 | 65 |
| Incorrect dose administered | 80 | 10.2% | 0 | 2 |
| Respiratory syncytial virus infection | 76 | 9.7% | 2 | 54 |
| Pyrexia | 54 | 6.9% | 0 | 29 |
| Cough | 45 | 5.8% | 0 | 25 |
| Respiratory syncytial virus test positive | 36 | 4.6% | 1 | 30 |
| Extra dose administered | 30 | 3.8% | 0 | 0 |
| Product storage error | 30 | 3.8% | 0 | 0 |
| Rash | 25 | 3.2% | 0 | 6 |
| Oxygen therapy | 22 | 2.8% | 0 | 22 |
| Product administered to patient of inappropriate age | 20 | 2.6% | 0 | 0 |
| Respiratory distress | 17 | 2.2% | 0 | 14 |
| Urticaria | 17 | 2.2% | 0 | 4 |
Other Indications for NIRSEVIMAB-ALIP
Respiratory syncytial virus immunisation (170)
Antiviral prophylaxis (137)
Immunisation (107)
Prophylaxis (26)
Respiratory syncytial virus infection (22)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)